Neuroone Medical Technologies (NMTC) Inventory Average (2021 - 2026)

Neuroone Medical Technologies' Inventory Average history runs 6 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• Quarterly Inventory Average rose 13.16% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 13.16% YoY) and the FY2025 annual result came in at $2.4 million, up 26.68% from the prior year.
• Inventory Average was $1.6 million for Q1 2026 at Neuroone Medical Technologies, down from $1.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $2.2 million in Q3 2024 and bottomed at $225509.0 in Q1 2022.
• A 5-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average soared 670.14% — and 2025, when it sank 31.8%.
• Neuroone Medical Technologies' Inventory Average stood at $804046.0 in 2022, then surged by 74.83% to $1.4 million in 2023, then gained by 26.3% to $1.8 million in 2024, then decreased by 8.77% to $1.6 million in 2025, then decreased by 3.93% to $1.6 million in 2026.
• Business Quant data shows NMTC's Inventory Average at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.